Statins li
Internal Medicine
2021-10-18

Statins linked to modest reduced mortality risk from COVID-19 in major population study

Statin treatment had a modest negative association with coronavirus disease 2019 (COVID-19) mortality, according to a study published in PLOS Medicine. Using data from Swedish health registers, Rita Bergqvist, Karolinska Institutet, Stockholm, Sweden, and colleagues followed 963,876 residents of Stockholm aged 45 or older from March 1, 2020 to November 11, 2020. The results are based on analyses of data on the participants’ prescribed medication and healthcare and from the Cause of Death Register. In the cohort, 169,642 (17.6%) individuals were statin users. Statin users were older (medi...

Study Esta
Internal Medicine
2021-10-15

Study Establishes the Value of Cardiovascular MRI for Suspected Cardiac Tumours

In a first-of-its-kind study, researchers have confirmed that cardiovascular magnetic resonance (CMR...

Treatment
Internal Medicine
2021-10-13

Treatment with monoclonal antibodies reduces risks of hospitalisation and progressing to severe...

Treatment with bamlanivimab, bamlanivimab-etesevimab, or casirivimab-imdevimab significantly decreas...

Videos from category: Cardiology

2021 ESC G
7:39

2021 ESC Guidelines - CVD Prevention

ESC 2021
SSaSS: Sal
3:42

SSaSS: Salt Substitute and Stroke Study into the effect of salt substitutes on cardiovascular events and death

ESC 2021
The RIPCOR
6:43

The RIPCORD 2 trial

ESC 2021
The new ad
12:00

The new advancements in angina

ESC 2021

Videos from category: Dermatology

Psoriasis
6:51

Psoriasis is a systemic disease

EADV 2020
New non-al
6:36

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

EADV 2020
New Resear
4:08

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

EADV 2020
New eviden
7:47

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

EADV 2020

Videos from category: Diabetology

The curren
14:50

The current issues in Hypoglycaemia

EASD 2021
Current gu
12:05

Current guidelines on diabetes management

EASD 2021
Accumulate
8:58

Accumulated CV data from SGLT2i outcomes trials

EASD 2020
Remission
10:22

Remission of type 2 diabetes with return of insulin secretory function restores normal pancreas morphology

EASD 2020

Videos from category: Gastroenterology

Duodenal m
11:01

Duodenal mucosal resurfacing shown to discontinue insulin treatment in majority of type 2 diabetes patients and aid weight loss

UEG 2020
Allergy-re
7:48

Allergy-related diseases and IBS

UEG 2020
How to seq
2:20

How to sequence advanced therapies in IBD

ECCO 2020
Transmural
4:50

Transmural healing in IBD

ECCO 2020

Videos from category: Hematology

Antithromb
5:30

Antithrombin Deficiency Registry, an Update

ISTH 2021
Abelacimab
13:53

Abelacimab for Prevention of Venous Thromboembolism

ISTH 2021
The QUAZAR
13:56

The QUAZAR AML-001 Maintenance Trial

EHA 2021
Novelties
7:52

Novelties in the treatment of Multiple Myeloma

EHA 2021

Videos from category: Internal Medicine

Important
8:39

Important messages from EULAR2021: Impact of air pollution on RA flares, effect of COVID-19 on RA care, osteoporosis care of men

EULAR 2021
Which are
4:59

Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?

PAINWeek 2020
What is th
14:04

What is the role of transdermal fentanyl patches in management of cancer pain?

PAINWeek 2020
Optimising
8:42

Optimising the monitoring and treatment of SSc-ILD

EULAR 2020

Videos from category: Oncology

The MONALE
8:37

The MONALEESA-2 trial

ESMO 2021
Spotlight
16:53

Spotlight on the emerging therapies: Multidisciplinary discussions (advanced RCC, HCC and DTC)

ESMO 2021
Should Cur
16:32

Should Cure Be A Reasonable Goal in aRCC?

ESMO 2021
The Keynot
7:05

The Keynote 716 trial

ESMO 2021

Videos from category: Psychiatry

Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Obstetric
6:010

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

EPA 2021
Consequenc
7:54

Consequences of COVID-19 Outbreak on Mental Health

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021

Videos from category: Respiratory

The digita
11:38

The digital age: The future of respiratory medicine

ERS 2021
ERS/EAACI
8:50

ERS/EAACI statement on adherence to international adult asthma guidelines

ERS 2021
Pulmonary
7:05

Pulmonary hypertension and interstitial pulmonary fibrosis

ERS 2021
Resetting
7:38

Resetting the agenda: a new approach to asthma in GINA 2019

ERS 2019

Videos from category: Urology

Balancing
13:20

Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma studies

EAU 2021

Suggested videos

By Author
By Topic
By Congress
4:21
Highlights of the 17th St. Gallen International Breast Cancer Conference
St. Gallen BCC 2021
7:07
KEYNOTE-024 5-year OS update: first-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumor proportion score (TPS) ≥50%
ESMO 2020
13:09
A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3
AHA 2020
11:06
IMpassion031: Results from a phase III study of neoadjuvant atezolizumab + chemotherapy in early triple-negative breast cancer
ESMO 2020
11:15
EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
ESC 2020
6:55
Relatlimab plus nivolumab versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047
ASCO 2021
15:58
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
ESC 2020
8:49
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma
ASCO 2020
16:51
Detailed summary of the Consensus Session of the SG-BCC 2021
St. Gallen BCC 2021
6:13
Breast cancer highlights from ESMO2020
ESMO 2020
6:22
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
ASH 2019
15:01
Cardiorenal risk in type 2 diabetes
EASD 2019
4:48
PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol
ACC 2021
3:25
Single cell RNA seq of immune infiltrates
EADO 2019
7:44
Summary of clinical and scientific topics discussed at EASD 2020 congress
EASD 2020
14:31
ESC Gold Medal 2020 Winner: Kari Stefansson
ESC 2020
5:09
ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
ACC 2021
9:42
De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
St. Gallen BCC 2021
9:01
A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial
AHA 2020
11:38
ESH-ISH 2021 Late-Breakers Session
ESH-ISH 2021
8:42
Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata
EADV 2019
6:09
PARADISE-MI: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction
ACC 2021
8:06
ISCHEMIA Trial: Impact Of Completeness Of Revascularization On Clinical Outcomes In Patients With Stable Ischemic Heart Disease Treated With An Invasive Vs. Conservative Strategy
ACC 2021
13:01
Latest trends, developments in breast surgery
St. Gallen BCC 2021
9:11
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
EHA 2020
7:02
Clinical Impact of Ibrutinib with R-CHOP in Untreated Non-GCB DLBCL Co-Expressing BCL2 and MYC Genes in the Phase 3 Phoenix Trial
ASH 2019
9:28
Trifluridine/tipiracil or regorafenib in refractory metastatic colorectal cancer patients: An AGEO prospective “real life” study
ASCO 2020
8:36
Why We Should Still Care about Glycemic Lowering Strategies for Type 2 Diabetes
EASD 2019
17:43
Recognizing and Addressing Risk in Patients with HR-positive, HER2-negative Early Breast Cancer
St. Gallen BCC 2021
Search by Scientific Content
Search by Congress
Search:
Date
Filters:
The curren
14:50
Title Description

The current issues in Hypoglycaemia

Presenter: Brian Frier
Diabetology : Diabetes
EASD 2021
Current gu
12:05
Title Description

Current guidelines on diabetes management

Presenter: Christoph Wanner
Diabetology : Diabetes
EASD 2021
Spotlight
16:53
Title Description

Spotlight on the emerging therapies: Multidisciplinary discussions (advanced RCC, HCC and DTC)

Presenter: Peter Galle
Oncology
ESMO 2021
The MONALE
8:37
Title Description

The MONALEESA-2 trial

Presenter: Gabriel N. Hortobagyi
Oncology
ESMO 2021
Should Cur
16:32
Title Description

Should Cure Be A Reasonable Goal in aRCC?

Presenter: David F. McDermott
Oncology
ESMO 2021
Is Unresec
6:32
Title Description

Is Unresectable Malignant Pleural Mesothelioma a New Frontier for I-O?

Presenter: Alessandra Curioni-Fontecedro
Oncology
ESMO 2021
The Keynot
7:05
Title Description

The Keynote 716 trial

Presenter: Jason J. Luke
Oncology
ESMO 2021
Navigating
5:56
Title Description

Navigating a New Era in HER2+ Metastatic Breast Cancer: Focus on HER2CLIMB

Presenter: Judy King
Oncology
ESMO 2021
Metastases
7:04

Metastases-free survival results from STAMPEDE trial

Presenter: Gerhardt Attard
Oncology
ESMO 2021
Navigating
5:19

Navigating a New Era in HER2+ Metastatic Breast Cancer: Focus on HER2CLIMB

Presenter: Wolfgang Janni
Oncology
ESMO 2021
Highlights
10:39
Title Description

Highlights of the ESMO 2021 Congress

Presenter: Solange Peters
Oncology
ESMO 2021
SSaSS: Sal
3:42
Title Description

SSaSS: Salt Substitute and Stroke Study into the effect of salt substitutes on cardiovascular events and death

Presenter: Bruce Neal
Cardiology
ESC 2021
2021 ESC G
7:39
Title Description

2021 ESC Guidelines - CVD Prevention

Presenter: Frank Visseren
Cardiology
ESC 2021
The digita
11:38
Title Description

The digital age: The future of respiratory medicine

Presenter: Henry Chrystyn
Respiratory
ERS 2021
Antithromb
5:30
Title Description

Antithrombin Deficiency Registry, an Update

Presenter: Zsuzsanna Bereczky
Hematology
ISTH 2021
Pulmonary
7:05
Title Description

Pulmonary hypertension and interstitial pulmonary fibrosis

Presenter: Vincent Cottin
Respiratory
ERS 2021

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology